AzTrials
AzTrials

AnemiaNCT03377777

The Effect of Anemia in Infancy on the Microbiome and Systemic Metabolism

An observational study of Anemia and Iron-deficiency, run by University of California, Davis.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Serum and fecal samples were collected from infants at either 6-7 m of age or 12-13 m of age. Serum and feces were analyzed locally for hemoglobin status or evidence of parasites, and standard of care was provided. Read more about this study

Who is it for?
Ages 6 to 13 monthsHealthy volunteers can take part
Conditions the study is for
Anemia, Iron-deficiency, Iron Deficiency Anemia
How many people
203 participants
Where
No sites listed yet
Study dates
1 Aug 2014to 30 Nov 2014
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 13 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Outwardly healthy 6-7 month, and 12-13 month male and female infants born at term with a birthweight > 2,500 g.

Who may be able to join

  • Outwardly healthy,
  • birthweight > 2,500 g
  • term births
  • residents in Moronacocha, Iquitos, Loreto

Who cannot join

  • Obvious signs of illness or malnutrition
  • birthweight < 2,500 g
  • preterm birth
  • not a resident of Moronacocha, Iquitos, Loreto

About this study

Official title: Development of Infants and Young Children Living in the Amazon Region of Peru: Relationship With Anemia, Chronic Malnutrition, and Gut Microbiota.

Serum and fecal samples were collected from infants at either 6-7 m of age or 12-13 m of age. Serum and feces were analyzed locally for hemoglobin status or evidence of parasites, and standard of care was provided. Excess serum was transported to UC Davis for metabolomics analysis and the University of Hohenheim for iron status assessment and measurement of inflammatory markers. Fecal samples were transported to UC Davis for measurement of the microbiome structure and function.

Read the detailed description

Sample collection occurred between August and November 2014. A total of 203 infants and their parents (101 at 6-7 m of age and 102 at 12-13 m of age) receiving care at the Moronacocha Health Center in Iquitos, Peru were recruited. All subjects were residents of Moronochocha, Iquitos, Loreto, outwardly healthy, and born at term with a birth weight of at least 2,500 g. Venous blood samples were collected by a lab technician at the local health center. Hemoglobin concentrations were immediately measured, and treatment given if warranted. Samples were subsequently transported to Selva Amazonica clinic, centrifuged, and serum was stored at -80 °C. Stool samples were collected by caregivers from diapers at home, taken to Selva Amazonica Clinic, and aliquoted. Fecal samples were analyzed for parasites at Selva Amazonica, and any necessary treatment was provided at the local health center. Serum and stool samples were shipped to UC Davis on dry ice, where they were stored at -80 °C until metabolomics and microbiome analyses. Serum aliquots were also shipped to the University of Hohenheim, Stuttgart, Germany for iron assessment, and measurement of inflammatory markers. All data integration and interpretation was performed at UC Davis.

Being tested
No intervention
Keywords
Anemia, Iron-deficiency, Iron-deficiency anemia, Infants, Metabolomics, Microbiome
Medical subject headings
Anemia, Anemia, Iron-Deficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionOther

Study groups in NCT03377777
Study groupRoleWhat they receive
InfantsOutwardly healthy male and female infants at 6-7 months or 12-13 months. No intervention.
Receives: Other: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anemia status

    Anemia status [Hb] ≤ 110 g/L

    Measured: 6-7 months or 12-13 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2017
  2. Study start1 Aug 2014
  3. Primary completion30 Nov 2014
  4. Study completion30 Nov 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
203 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03377777
Sponsor's protocol ID
GAIN08112014
Other IDs
00000000
Status last verified
Jan 2018
First submitted
11 Dec 2017
Last updated
30 Jan 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Microbiome sequencing data will be shared in a public repository (with iron status included as meta data).

Publications

  • McClorry S, Zavaleta N, Llanos A, Casapia M, Lonnerdal B, Slupsky CM. Anemia in infancy is associated with alterations in systemic metabolism and microbial structure and function in a sex-specific manner: an observational study. Am J Clin Nutr. 2018 Dec 1;108(6):1238-1248. doi: 10.1093/ajcn/nqy249.

    PubMed 30351381

Questions about this trial

What is this clinical trial studying?

An observational study of Anemia and Iron-deficiency, run by University of California, Davis.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anemia status (time frame: 6-7 months or 12-13 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03377777, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in